Table 2 Logistic regression analyses for any increases in eGFR
Variables | All patients (N = 40) | |||||
|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
95% CI | Odds ratio | p value | 95% CI | Odds ratio | p value | |
Age | – | – | 0.154 | |||
Male | – | – | 0.912 | |||
Body mass index | 0.99–1.39 | 1.17 | 0.041 | – | – | 0.265 |
Systolic blood pressure | – | – | 0.145 | |||
Heart rate | – | – | 0.671 | |||
HbA1c | – | – | 0.520 | |||
Fasting blood sugar | – | – | 0.311 | |||
Left ventricular ejection fraction | – | – | 0.797 | |||
Ischemic etiology | – | – | 0.816 | |||
Atrial fibrillation | – | – | 0.869 | |||
Hemoglobin | – | – | 0.199 | |||
Hematocrit | – | – | 0.176 | |||
Serum albumin | – | – | 0.068 | |||
Serum sodium | – | – | 0.062 | |||
Serum potassium | – | – | 0.685 | |||
eGFR | – | – | 0.897 | |||
BNP (per 163 pg/mL increase) | 0.16–0.88 | 0.37 | 0.016 | 0.08–0.79 | 0.26 | 0.007 |
NT-proBNP | – | – | 0.163 | |||
Beta–blockers | – | – | 0.100 | |||
ACEI/ARB | NA | NA | 0.009 | NA | NA | 0.002 |
Loop diuretics | – | – | 0.370 | |||
Furosemide (per 10 mg/day increase) | – | – | 0.077 | |||
MRA | – | – | 0.696 | |||
Thiazides | – | – | 0.182 | |||
Statin | – | – | 0.704 | |||
Sulfonylureas | – | – | 0.950 | |||
DPP-4i | – | – | 0.507 | |||
Biguanides | – | – | 0.869 | |||
Insulin | NA | NA | 0.030 | – | – | 0.103 |